Arbutus Biopharma Corp ABUS:NASDAQ

Last Price$3.70Cboe Previous Close - Real-Time Last Sale as of 4:35PM ET 12/06/21
Cboe Real-Time Quotes
Today's Change0(0.00%)
Bid (Size)$4.07 (18)
Ask (Size)$4.08 (100)
Day Low / HighN/A - N/A
Volume1.9 M

View Biotechnology IndustryPeer Comparison as of 12/06/2021


Arbutus Biopharma Corp ( NASDAQ )

Price: $3.70
Change: -0.01 (0.27%)
Volume: 1.9 M
4:35PM ET 12/06/2021

Sierra Oncology Inc ( NASDAQ )

Price: $23.40
Change: +0.20 (0.86%)
Volume: 28.4 K
4:00PM ET 12/06/2021

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A

Neoleukin Therapeutics Inc ( NASDAQ )

Price: $5.40
Change: +0.19 (3.65%)
Volume: 256.0 K
4:00PM ET 12/06/2021

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A

Read more news Recent News

Insider Sell: Arbutus Biopharma
7:29AM ET 12/06/2021 MT Newswires

Michael J. Sofia, Chief Scientific Officer, on December 01, 2021, sold 200,000 shares in Arbutus Biopharma (ABUS) for $1,018,000. Following the Form 4...

Sector Update: Health Care Stocks Holding Up After Market Reversal Wednesday
4:02PM ET 12/01/2021 MT Newswires

Health care stocks escaped the brunt of Wednesday's late selloff, with the NYSE Health Care Index still rising 0.8% while the Health Care Select Sector...

Sector Update: Health Care
3:40PM ET 12/01/2021 MT Newswires

Health care stocks sidestepped a portion of Wednesday's late selloff, with the NYSE Health Care Index rising 0.8% while the SPDR Health Care Select Sector...

Arbutus Biopharma Shares Soar After Early Data Indicates Antiviral Activity For Chronic Hepatitis B Virus Treatment
2:54PM ET 12/01/2021 MT Newswires

Arbutus Biopharma (ABUS) shares surged intraday Wednesday after the company said an ongoing early-stage trial showed that its capsid inhibitor, AB-836,...

Company Profile

Business DescriptionArbutus Biopharma Corp. is a biopharmaceutical company. It engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA. View company web site for more details
Address701 Veterans Circle
Warminster, Pennsylvania 18974
Number of Employees80
Recent SEC Filing12/03/20214
President, Chief Executive Officer & DirectorWilliam H. Collier
Chief Financial & Accounting OfficerDavid C. Hastings
Chief Scientific OfficerMichael J. Sofia
Secretary, Chief Compliance Officer & EVPElizabeth Howard

Company Highlights

Price Open$3.99
Previous Close$3.71
52 Week Range$2.43 - 6.50
Market Capitalization$500.5 M
Shares Outstanding135.3 M
SectorHealth Technology
Next Earnings Announcement03/03/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.90
Beta vs. S&P 500N/A
Revenue$5.9 M
Net Profit Margin-707.79%
Return on Equity-64.39%

Analyst Ratings as of 08/12/2021

Consensus RecommendationConsensus Icon
Powered by Factset